The Experts below are selected from a list of 258 Experts worldwide ranked by ideXlab platform
Sherrie S. Epstein - One of the best experts on this subject based on the ideXlab platform.
-
Issues in Psychiatric Hospital care
Current Opinion in Psychiatry, 1991Co-Authors: Robert A. Dorwart, Sherrie S. EpsteinAbstract:Private Psychiatric Hospital care continues to grow despite pressures on Hospitals both to keep beds filled and to manage care cost effectively. Budget cuts continue to plague public programs and private Hospitals have limited ability to respond to care of the seriously mentally ill. Adding to the problem of providing quality care to all who need it are managed care and utilization review, mandated by insurers, who more often are concerned with controlling costs than with ensuring quality of care. In the 1990s, subspecialization appears to be a significant evolving trend in Psychiatric Hospital care.
Brian B. Sheitman - One of the best experts on this subject based on the ideXlab platform.
-
Characteristics of Violent Behavior in a Large State Psychiatric Hospital
Psychiatric Services, 2004Co-Authors: John E. Kraus, Brian B. SheitmanAbstract:Violent behavior is a significant problem in Psychiatric Hospitals. The authors reviewed Hospital incident reports to identify the characteristics of violent behavior in a large state Psychiatric Hospital. They found that a very small percentage of patients accounted for a majority of violent episodes, that rates of violent behavior varied among Hospital units, that assaultive behavior was more common than self-harm in the long-term units, and that most commonly the assault victims were other patients. The data support earlier studies demonstrating that a small number of patients are responsible for a majority of violent episodes in a Hospital setting.
Robert A. Dorwart - One of the best experts on this subject based on the ideXlab platform.
-
Issues in Psychiatric Hospital care
Current Opinion in Psychiatry, 1991Co-Authors: Robert A. Dorwart, Sherrie S. EpsteinAbstract:Private Psychiatric Hospital care continues to grow despite pressures on Hospitals both to keep beds filled and to manage care cost effectively. Budget cuts continue to plague public programs and private Hospitals have limited ability to respond to care of the seriously mentally ill. Adding to the problem of providing quality care to all who need it are managed care and utilization review, mandated by insurers, who more often are concerned with controlling costs than with ensuring quality of care. In the 1990s, subspecialization appears to be a significant evolving trend in Psychiatric Hospital care.
Søren Østergaard - One of the best experts on this subject based on the ideXlab platform.
-
Incident psychopharmacological treatment and Psychiatric Hospital contact in individuals with newly developed type 2 diabetes - a register-based cohort study.
Acta neuropsychiatrica, 2020Co-Authors: Christopher Rohde, Norbert Schmitz, Reimar Werner Thomsen, Søren ØstergaardAbstract:To investigate the association between newly developed type 2 diabetes (T2D) and incident psychopharmacological treatment and Psychiatric Hospital contact. Via Danish registers, we identified all 56 640 individuals from the Central and Northern Denmark Regions with newly developed T2D (defined by the first HbA1c measurement ≥6.5%) in 2000-2016 as well as 315 694 age- and sex-matched controls (without T2D). Those having received psychopharmacological treatment or having had a Psychiatric Hospital contact in the 5 years prior to the onset of T2D were not included. For this cohort, we first assessed the 2-year incidence of psychopharmacological treatment and Psychiatric Hospital contact. Secondly, via Cox regression, we compared the incidence of psychopharmacological treatment/Psychiatric Hospital contact among individuals with T2D to propensity score-matched controls - taking a wide range of potential confounders into account. Finally, via Cox proportional hazards regression, we assessed which baseline (T2D onset) characteristics were associated with subsequent psychopharmacological treatment and Psychiatric Hospital contact. A total of 8.3% of the individuals with T2D initiated psychopharmacological treatment compared to 4.6% of the age- and sex-matched controls. Individuals with T2D were at increased risk of initiating psychopharmacological treatment compared to the propensity score-matched controls (HR = 1.51, 95% CI = 1.43-1.59), whereas their risk of Psychiatric Hospital contact was not increased to the same extent (HR = 1.14, 95% CI = 0.98-1.32). Older age, somatic comorbidity, and being divorced/widowed were associated with both psychopharmacological treatment and Psychiatric Hospital contact following T2D. Individuals with T2D are at elevated risk of requiring psychopharmacological treatment.
-
Incident psychopharmacological treatment and Psychiatric Hospital contact in individuals with newly developed type 2 diabetes
2020Co-Authors: Christopher Rohde, Norbert Schmitz, Reimar Werner Thomsen, Søren ØstergaardAbstract:Objective: To investigate the association between newly developed type 2 diabetes (T2D) and incident psychopharmacological treatment and Psychiatric Hospital contact. Methods: We identified all individuals from the Central- and Northern Denmark Regions with newly developed T2D (defined by the first HbA1c measurement >6.5%) from 2000-2016 and up to five age and sex matched individuals without T2D (controls). Those having received psychopharmacological treatment or having had a Psychiatric Hospital contact in the five years prior to the onset of T2D were excluded. For this cohort, we first assessed the incidence of psychopharmacological treatment and Psychiatric Hospital contact among individuals with T2D and controls, respectively. Secondly, we compared the incidence of psychopharmacological/Psychiatric Hospital contact among individuals with T2D to propensity score matched controls. Finally, we assessed which baseline (T2D onset) characteristics that were associated with subsequent psychopharmacological treatment and Psychiatric Hospital contact. Results: We identified 56,640 individuals with newly developed T2D and 315,694 controls. A total of 8.3% of the individuals with T2D initiated psychopharmacological treatment within the 2 years following onset compared to 4.6% among the age and sex matched controls. Individuals with T2D were at increased risk of initiating psychopharmacological treatment compared to the propensity score matched controls (HR=1.51, 95% CI=1.43-1.59), whereas their risk of Psychiatric Hospital contact was not increased to the same extent (HR=1.14, 95% CI=0.98-1.32). Older age, somatic comorbidity, and being divorced/widowed was associated with both psychopharmacological treatment and Psychiatric Hospital contact following T2D. Conclusion: Individuals with T2D are at elevated risk of requiring psychopharmacological treatment.
Keith Hawton - One of the best experts on this subject based on the ideXlab platform.
-
suicide in Psychiatric Hospital in patients risk factors and their predictive power
British Journal of Psychiatry, 2000Co-Authors: John Powell, John R Geddes, Jonathan J Deeks, Michael J Goldacre, Keith HawtonAbstract:Background Psychiatric Hospital inpatients are known to be at high risk of suicide, yetthere is little reliable knowledge of risk factors or their predictive power. Aims To identify risk factors for suicide in Psychiatric Hospital in-patients and to evaluate their predictive power in detecting people at risk of suicide. Method Using a case-control design, 112 people who committed suicide while in-patients in Psychiatric Hospitals were compared with 112 randomly selected controls. Univariate analysis and multivariate analyses were used to estimate odds ratios and adjusted likelihood ratios. Results The rate of suicide in Psychiatric in-patients was 13.7 (95% CI 11.7-16.1) per 10 000 admissions. There were five predictive factors with likelihood ratios >2, following adjustment: planned suicide attempt, 4.1; actual suicide attempt, 4.9; recent bereavement, 4.0; presence of delusions, 2.3; chronic mental illness, 2.2; and family history of suicide, 4.6. On this basis, only two of the patients who committed suicide had a predicted risk of suicide above 5%. Conclusions Although several factors were identified that were strongly associated with suicide, their clinical utility is limited by low sensitivity and specificity, combined with the rarity of suicide, even in this high-risk group.
